Lymphoblastic leukaemia is a heterogeneous disease of children and adults resulting from clonal expansion of progenitor cells. Treatment with intensive cytotoxic therapy is effective in the majority of children, but treatments for adults are less effective, probably because the disease originates from relatively drug-resistant stem cells.
Keywords: leukaemia; clinical trials; bone marrow transplantation; molecular genetics




